Glutamine as a component of support therapy in the treatment of solid tumors
Introduction. Mucositis is one of the most common side effects of antitumor treatment. Materials and methods. The review article analyzes the data available in the literature on the biological role of glutamine, pathogenetic mechanisms of protective action, and evaluates its clinical effectiveness in reducing the risk of developing mucositis. Results and discussion. Oral administration of glutamine in a daily dose of 30 g, combined with optimal nutritional support, demonstrated a significant clinical effect: a decrease in the frequency and severity of mucositis, a delay in their manifestation, and a reduction in the duration of repair of damaged mucous membranes. Conclusions. From the point of view of evidence-based medicine, the appointment of oral forms of glutamine for the prevention and treatment of chemo/radio-induced oral mucositis can be considered the most reasonable. Further large-scale, placebo-controlled studies are needed.
Authors
- Mariya Y. Kukosh (ORCID: https://orcid.org/0000-0001-6481-1724)
Institutions
- Peoples' Friendship University of Russia (RU)
- Medical Radiological Research Center (RU)
- Melanoma Institute Australia (AU)
- Northern California Melanoma Center (US)
Publication Details
- Journal
- Medical alphabet
- Published
- 2026-11-17
- DOI
- https://doi.org/10.33667/2078-5631-2026-27-16-21
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00